WINNIPEG, Manitoba, Feb. 19 (UPI) — An increased dosage of Tamiflu, or oseltamivir, for patients with severe H1N1 influenza is unlikely to be required, Canadian researchers suggest. (Source: Health News – UPI.com)

Further information:

Article source

Related posts:

1. Gastrointestinal absorption of Tamiflu in critically ill patients with H1N1
2. Severely Ill Patients With H1N1 Do Not Require Higher Tamiflu Doses
3. Pandemic flu, like seasonal H1N1, shows signs of resisting Tamiflu
4. Babies may be born bilingual
5. Support, training needed for chronically ill patients